Dr. Julian Segan talks with Dr. Bryant England about abstract 0245 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0245: Influence of Forced Vital Capacity Impairment on Treatment Selection and Outcomes in RA-ILD Patients Initiating a Biologic or Targeted-Synthetic DMARD
- Күн бұрын
Treatment Choices and Mortality in RA-ILD
- Рет қаралды 1,426
Пікірлер